🔗 Share this article

Chancellor Reeves has revealed she is planning "focused steps to tackle cost of living issues" in next month's Budget.

Speaking to media outlets, she noted that reducing price rises is a collective task of both the government and the Bank of England.

The UK's inflation rate is projected to be the highest among the G7 industrialized countries this calendar year and next.

Potential Utility Bill Measures

Sources suggest the government could take action to lower utility costs, for example by reducing the current 5% level of VAT applied on energy supplies.

An additional possibility is to reduce some of the government charges presently included in bills.

Budgetary Constraints and Expert Expectations

The government will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much room there is for these measures.

The expectation from the majority of economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to meet her self-imposed fiscal targets.

Earlier on Thursday, analysis suggested there was a £22bn deficit for the Treasury chief to fill, which is at the more modest range of expectations.

"There's a shared job between the Bank of England and the government to continue tackling some of the sources of price increases," Reeves stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent information from the OBR had not changed her vow to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with increasing international and trade tensions for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Disputes

Commenting on worries about the United Kingdom's economic relations with China she said: "The UK's national security always are paramount."

Recent statement by China to tighten export controls on critical minerals and other resources that are essential for high-technology production led American leader the US President to propose an additional 100% tariff on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief labeled the Chinese action "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the US offer to participate in its battle with China, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the world economy and causes additional challenges."

"I believe there are sectors where we need to address Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including banking sector and other areas of the economy. We've got to achieve that balance correct."

The Treasury chief also confirmed she was collaborating with G7 counterparts "on our own critical minerals plan, so that we are more independent."

Health Service Drug Pricing and Funding

The Chancellor also recognized that the price the National Health Service pays for medicines could go up as a consequence of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning projects in the UK, with some attributing the insufficient payments they are obtaining.

Recently, the Science Minister said the price the health service spends on drugs would must go up to halt companies and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "It has been observed as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been provided in the UK in the manner that they are in other EU nations."

"The objective is to ensure that patients receiving care from the National Health Service are can receive the finest life-saving treatments in the globe. And so we are reviewing all of that, and... seeking to obtain increased funding into the UK."